Please login to the form below

Not currently logged in
Email:
Password:

Greenleaf Health appoints drug and biological products principal

Dr John Jenkins joins the FDA regulatory consulting firm

Washington, US-based Greenleaf Health has appointed Dr John Jenkins as principal for drug and biological products.

Dr Jenkins brings over 25 years of experience from the US Food and Drug Administration (FDA) to the regulatory consulting firm, and is set to oversee its clients' drug development programmes through regulatory submission and post-approval requirements.

Most recently, he served as director of the office of new drugs within the FDA's Center for Drug Evaluation and Research. He previously held several leadership positions at the regulatory body, including director of the office of drug evaluation and director of the division of pulmonary drug products.

Patrick Ronan, chief executive of Greenleaf Health, said: “No one is more qualified than John to provide our clients strategic and technical guidance on FDA's regulatory process for drug and biological product development.

“Our experts at Greenleaf, who have a combined total of more than 200 years of FDA experience, help our clients navigate complex regulatory challenges. John's knowledge and experience in this area are unrivaled, and he makes a great addition to our team.”

20th February 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics